Drug therapy for chronic myeloid leukaemia

Question: In patients with recently diagnosed and minimally treated chronic myeloid leukaemia (CML) who are considered suitable for systemic induction and maintenance therapy during the chronic phase, does the use of interferon (IFN) prolong survival compared with busulphan or hydroxyurea? Perspectives: Evidence was selected and reviewed by a working group of five haematologist, three of whom serve with the Hematological Cancer Disease Site …